nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroxoline—METAP2—adrenal cortex—polycystic ovary syndrome	0.123	0.142	CbGeAlD
Nitroxoline—METAP2—endometrium—polycystic ovary syndrome	0.11	0.127	CbGeAlD
Nitroxoline—METAP2—uterus—polycystic ovary syndrome	0.101	0.117	CbGeAlD
Nitroxoline—METAP2—pituitary gland—polycystic ovary syndrome	0.0993	0.115	CbGeAlD
Nitroxoline—METAP2—adipose tissue—polycystic ovary syndrome	0.0989	0.115	CbGeAlD
Nitroxoline—METAP2—adrenal gland—polycystic ovary syndrome	0.0887	0.103	CbGeAlD
Nitroxoline—METAP2—female gonad—polycystic ovary syndrome	0.0827	0.0959	CbGeAlD
Nitroxoline—METAP2—vagina—polycystic ovary syndrome	0.0822	0.0953	CbGeAlD
Nitroxoline—METAP2—endocrine gland—polycystic ovary syndrome	0.0769	0.0892	CbGeAlD
Nitroxoline—METAP2—Diseases associated with visual transduction—AKR1C1—polycystic ovary syndrome	0.015	0.109	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—RBP4—polycystic ovary syndrome	0.0138	0.0999	CbGpPWpGaD
Nitroxoline—METAP2—Diseases associated with visual transduction—AKR1C3—polycystic ovary syndrome	0.0115	0.0836	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NMNAT3—polycystic ovary syndrome	0.00473	0.0343	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00437	0.0317	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00437	0.0317	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00303	0.022	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NPB—polycystic ovary syndrome	0.00265	0.0192	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RPL37A—polycystic ovary syndrome	0.00244	0.0177	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.0024	0.0174	CbGpPWpGaD
Nitroxoline—METAP2—Disease—HMMR—polycystic ovary syndrome	0.00231	0.0167	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00221	0.016	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00221	0.016	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00207	0.015	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00201	0.0145	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00195	0.0142	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.0019	0.0138	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKR1C1—polycystic ovary syndrome	0.0019	0.0138	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00178	0.0129	CbGpPWpGaD
Nitroxoline—METAP2—Disease—FGF18—polycystic ovary syndrome	0.00177	0.0128	CbGpPWpGaD
Nitroxoline—METAP2—Disease—RBP4—polycystic ovary syndrome	0.00175	0.0127	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00162	0.0117	CbGpPWpGaD
Nitroxoline—METAP2—Disease—GAB1—polycystic ovary syndrome	0.00161	0.0117	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NAMPT—polycystic ovary syndrome	0.00157	0.0114	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00152	0.011	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00148	0.0107	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKR1C3—polycystic ovary syndrome	0.00146	0.0106	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FST—polycystic ovary syndrome	0.00144	0.0105	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TNRC6B—polycystic ovary syndrome	0.00144	0.0105	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00142	0.0103	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LHB—polycystic ovary syndrome	0.00141	0.0102	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00138	0.00997	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00133	0.00966	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SCT—polycystic ovary syndrome	0.00132	0.00956	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00126	0.00912	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00124	0.00896	CbGpPWpGaD
Nitroxoline—METAP2—Disease—TCF7L2—polycystic ovary syndrome	0.00123	0.00895	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00123	0.00889	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SLC2A4—polycystic ovary syndrome	0.00121	0.0088	CbGpPWpGaD
Nitroxoline—METAP2—Disease—PRL—polycystic ovary syndrome	0.00116	0.00839	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00114	0.0083	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00113	0.00818	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—INSR—polycystic ovary syndrome	0.00108	0.00782	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.00103	0.00743	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00101	0.00732	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PGR—polycystic ovary syndrome	0.001	0.00725	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NCOR1—polycystic ovary syndrome	0.00097	0.00703	CbGpPWpGaD
Nitroxoline—METAP2—Disease—NRG1—polycystic ovary syndrome	0.000952	0.0069	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000929	0.00674	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000929	0.00674	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000887	0.00643	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000865	0.00627	CbGpPWpGaD
Nitroxoline—METAP2—Disease—MTHFR—polycystic ovary syndrome	0.000858	0.00622	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000818	0.00593	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IRS2—polycystic ovary syndrome	0.000816	0.00591	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000811	0.00588	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000769	0.00558	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000713	0.00517	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IRS1—polycystic ovary syndrome	0.000712	0.00516	CbGpPWpGaD
Nitroxoline—METAP2—Disease—INS—polycystic ovary syndrome	0.000682	0.00494	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00068	0.00492	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000667	0.00483	CbGpPWpGaD
Nitroxoline—METAP2—Disease—AKT2—polycystic ovary syndrome	0.000659	0.00478	CbGpPWpGaD
Nitroxoline—METAP2—Disease—SERPINE1—polycystic ovary syndrome	0.000627	0.00454	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000571	0.00414	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000559	0.00405	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000499	0.00361	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—POMC—polycystic ovary syndrome	0.00048	0.00348	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—INS—polycystic ovary syndrome	0.000478	0.00346	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000462	0.00335	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000462	0.00335	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000439	0.00318	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000302	0.00219	CbGpPWpGaD
Nitroxoline—METAP2—Disease—IL6—polycystic ovary syndrome	0.000298	0.00216	CbGpPWpGaD
Nitroxoline—METAP2—Signaling Pathways—IL6—polycystic ovary syndrome	0.000209	0.00151	CbGpPWpGaD
